Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Metastatic Breast Carcinoma;   Prognostic Stage IV Breast Cancer AJCC v8
Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Diagnostic Laboratory Biomarker Analysis;   Other: Medical Chart Review
Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 27, 2020 / by / in
Comments